Stay updated with breaking news from Eliza Sun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hansoh's HS-20093 builds on GSK's oncology portfolio of clinical-stage antibody-drug conjugates, following earlier agreement for Hansoh's HS-20089 focused on gynaecologic cancers ...
The exclusive license agreement will give GSK rights to Hansoh’s HS-20093, a B7-H3 targeted ADC that’s being investigated in several cancers.
- Hansoh's HS-20093 builds on GSK's oncology portfolio of clinical-stage antibody-drug conjugates, following earlier agreement for Hansoh's HS-20089 focused on gynaecologic cancers - HS-20093 has...
- KiOmedinevsOne is a non-animal sourced chitosan injection that has been launched in Europe for the treatment of knee osteoarthritis. - KiOmed Pharma
KiOmedinevsOne is a non-animal sourced chitosan injection that has been launched in Europe for the treatment of knee osteoarthritis. KiOmed Pharma is eligible to receive upfront fee and milestone